ONLINE DATABASE SEARCH - OI-LS-323-MEMO
1. 45351 OI-LS-323; PUBMED-OI-5/31/2005
Antimycobacterial Agents Differ with Respect to Their Bacteriostatic versus Bactericidal Activities in Relation to Time of Exposure, Mycobacterial Growth Phase, and Their Use in Combination
Bakker-Woudenberg, IA, van Vianen, W, van Soolingen, D, Verbrugh, HA, and van Agtmael, MA
Antimicrob Agents Chemother 2005. 49(6): 2387-2398
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15917538&dopt=abstract
2. 45352 OI-LS-323; PUBMED-OI-5/31/2005
Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis
Tyagi, S, Nuermberger, E, Yoshimatsu, T, Williams, K, Rosenthal, I, Lounis, N, Bishai, W, and Grosset, J
Antimicrob Agents Chemother 2005. 49(6): 2289-2293
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15917523&dopt=abstract
3. 45353 OI-LS-323; PUBMED-OI-5/31/2005
Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation
Dash, S, Prabhu, R, Hazari, S, Bastian, F, Garry, R, Zou, W, Haque, S, Joshi, V, Regenstein, FG, and Thung, SN
Liver Int 2005. 25(3): 580-594
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15910496&dopt=abstract
4. 45354 OI-LS-323; PUBMED-OI-5/31/2005
Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses
Bretner, M, Najda, A, Podwinska, R, Baier, A, Paruch, K, Lipniacki, A, Piasek, A, Borowski, P, and Kulikowski, T
Acta Pol Pharm 2004. 61 Suppl: 26-28
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15909930&dopt=abstract
5. 45355 OI-LS-323; SCIFINDER-OI-5/24/2005
Synthesis and antifungal activity of 2/3-arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy-1,4-naphthoquinones
Ryu, Chung-Kyu, Shim, Ju-Yeon, Chae, Mi Jin, Choi, Ik Hwa, Han, Ja-Young, Jung, Ok-Jai, Lee, Jung Yoon, and Jeong, Seong Hee
European Journal of Medicinal Chemistry 2005. 40(5): 438-444
6. 45356 OI-LS-323; PUBMED-OI-5/31/2005
Molecular dynamics simulation studies of the wild-type, I21V and I16T mutants of isoniazid resistant Mycobacterium tuberculosis Enoyl Reductase (InhA) in complex with NADH: Towards the understanding of NADH-InhA different affinities
Schroeder, EK, Basso, LA, Santos, DS, and Norberto, de Souza O
Biophys J 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15908576&dopt=abstract
7. 45357 OI-LS-323; PUBMED-OI-5/31/2005
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P, Reed, MB, and Barry, CE
Infect Immun 2005. 73(6): 3492-3501
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15908378&dopt=abstract
8. 45358 OI-LS-323; PUBMED-OI-5/31/2005
Racemic and optically active 2-methoxy-4-oxatetradecanoic acids: novel synthetic fatty acids with selective antifungal properties
Carballeira, NM, O'neill, R, and Parang, K
Chem Phys Lipids 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15899476&dopt=abstract
9. 45359 OI-LS-323; PUBMED-OI-5/31/2005
Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence
Munoz-Elias, EJ and McKinney, JD
Nat Med 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15895072&dopt=abstract
10. 45360 OI-LS-323; PUBMED-OI-5/31/2005
Use of an animal model of disseminated candidiasis in the evaluation of antifungal therapy
Andes, D
Methods Mol Med 2005. 118: 111-128
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15888938&dopt=abstract
11. 45361 OI-LS-323; SCIFINDER-OI-5/24/2005
Total syntheses of the novel (+-)-2-methoxy-4-oxatetradecanoic acid and (S)-2-methoxy-4-oxatetradecanoic acid
O'Neill, Rosann and Carballeira, Nestor M
229th ACS National Meeting 2005.: ORGN-813
12. 45362 OI-LS-323; PUBMED-OI-5/31/2005
The inhibition of Candida albicans by selected essential oils and their major components
Tampieri, MP, Galuppi, R, Macchioni, F , Carelle, MS, Falcioni, L, Cioni, PL, and Morelli, I
Mycopathologia 2005. 159(3): 339-345
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15883716&dopt=abstract
13. 45363 OI-LS-323; PUBMED-OI-5/31/2005
In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA
Dutta, NK, Mazumdar, K, Dastidar, SG, Chakrabarty, AN, Shirataki, Y, and Motohashi, N
In Vivo 2005 . 19(3): 539-545
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15875773&dopt=abstract
14. 45364 OI-LS-323; SCIFINDER-OI-5/24/2005
Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity
Tenorio, Romulo P, Carvalho, Cristiane S, Pessanha, Carla S, de Lima, Jose G, de Faria, Antonio R, Alves, Antonio J, de Melo, Edesio JT, and Goes, Alexandre JS
Bioorganic & Medicinal Chemistry Letters 2005. 15(10): 2575-2578
15. 45365 OI-LS-323; SCIFINDER-OI-5/24/2005
Crystallization and preliminary X-ray crystallographic analysis of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Mycobacterium tuberculosis
Webby, Celia J, Lott, JShaun, Baker, Heather M, Baker, Edward N, and Parker, Emily J
Acta Crystallographica, Section F: Structural Biology and Crystallization Communications 2005. F61(4): 403-406
16. 45366 OI-LS-323; WOS-OI-5/22/2005
Cytotoxicity, antitumoral and antimycobacterial activity of tetrazole and oxadiazole derivatives
De Souza, AO, Pedrosa, MTC, Alderete, JB, Cruz, AF, Prado, MAF, Alves, RB, and Silva, CL
PHARMAZIE 2005. 60(5): 396-397, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228942400016
17. 45367 OI-LS-323; SCIFINDER-OI-5/24/2005
Pharmacokinetics of antiviral agents for the treatment of cytomegalovirus infection
Baillie, GMark
American Journal of Health-System Pharmacy 2005. 62(Suppl. 1): S14-S17
18. 45368 OI-LS-323; SCIFINDER-OI-5/24/2005
Design, Synthesis and Antiviral Activity of Novel 4,5-Disubstituted 7-(b-D-Ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the Novel 3-Amino-5-methyl-1-(b-D-ribofuranosyl)- and 3-Amino-5-methyl-1-(2-deoxy-b-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as Analogues of Triciribine
Migawa, Michael T, Drach, John C, and Townsend, Leroy B
Journal of Medicinal Chemistry 2005. 48(11): 3840-3851
19. 45369 OI-LS-323; SCIFINDER-OI-5/24/2005
Antiviral activities of plant triterpenes, their derivatives and ribavirin phosphonates
Il'icheva, TN, Kulishova, LA, Shul'ts, EE, Petrenko, NI, Uzenkova, NV, Yas'ko, MV, Serova, OA, Volkov, GN, Belanov, EF, Tolstikov, GA, and Pokrovskii, AG
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005.(2): 26-30
20. 45370 OI-LS-323; SCIFINDER-OI-5/24/2005
In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication
Kern, Earl R, Kushner, Nicole L, Hartline, Caroll B, Williams-Aziz, Stephanie L, Harden, Emma A, Zhou, Shaoman, Zemlicka, Jiri, and Prichard, Mark N
Antimicrobial Agents and Chemotherapy 2005. 49(3): 1039-1045
21. 45371 OI-LS-323; WOS-OI-5/22/2005
Synthesis and antimycobacterial activity of 7-O-substituted-4-methyl-2H-2-chromenone derivatives vs Mycobacterium tuberculosis
Yee, SW, Shah, B, and Simons, C
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2005. 20(2): 109-113, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228805000001
22. 45372 OI-LS-323; WOS-OI-5/22/2005
Anticandidal properties of N-acylpeptides containing an inhibitor of glucosamine-6-phosphate synthase
Andruszkiewicz, R, Zieniawa, T, and Walkowiak, A
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2005. 20(2): 115-121, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228805000002
23. 45373 OI-LS-323; WOS-OI-5/22/2005
Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives
Kaplancikli, ZA, Turan-Zitouni, G, and Chevallet, P
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2005. 20(2): 179-182, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228805000009
24. 45374 OI-LS-323; WOS-OI-5/22/2005
In-vitro antibacterial, antifungal and cytotoxic properties of sulfonamide-derived Schiff's bases and their metal complexes
Chohan, ZH, Ul-Hassan, M, Khan, KM, and Supuran, CT
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2005. 20(2): 183-188, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228805000010
25. 45375 OI-LS-323; WOS-OI-5/22/2005
Crystal structure of Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase
Dey, S, Grant, GA, and Sacchettini, JC
JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(15): 14892-14899, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228236800068
26. 45376 OI-LS-323; SCIFINDER-OI-5/24/2005
Use of indomethacin and indomethacin derivatives as broad-spectrum antiviral drugs, and corresponding pharmaceutical compositions
Santoro, Maria Gabriella
PATENT: WO 2005013980 ISSUE DATE: 20050217
APPLICATION: 2004 PP: 24 pp.
ASSIGNEE: (Universita' Degli Studi di Roma 'tor Vergata', Italy
27. 45377 OI-LS-323; SCIFINDER-OI-5/24/2005
Synthesis and Evaluation of S-Acyl-2-thioethyl Esters of Modified Nucleoside 5'-Monophosphates as Inhibitors of Hepatitis C Virus RNA Replication
Prakash, Thazha P, Prhavc, Marija, Eldrup, Anne B, Cook, PDan, Carroll, Steven S, Olsen, David B, Stahlhut, Mark W, Tomassini, Joanne E, MacCoss, Malcolm, Galloway, Sheila M, Hilliard, Catherine, and Bhat, Balkrishen
Journal of Medicinal Chemistry 2005. 48(4): 1199-1210
28. 45378 OI-LS-323; SCIFINDER-OI-5/24/2005
Synthesis of 2'-b-C-methyl toyocamycin and sangivamycin analogs as potential HCV inhibitors
Ding, Yili, An, Haoyun, Hong, Zhi, and Girardet, Jean-Luc
Bioorganic & Medicinal Chemistry Letters 2005. 15(3): 725-727
29. 45379 OI-LS-323; WOS-OI-5/22/2005
Molecular epidemiology: A tool for understanding control of tuberculosis transmission
Daley, CL
CLINICS IN CHEST MEDICINE 2005. 26(2): 217-+, 16
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228823000006
30. 45380 OI-LS-323; WOS-OI-5/22/2005
New drugs for tuberculosis: Current status and future prospects
O'Brien, RJ and Spigelman, M
CLINICS IN CHEST MEDICINE 2005. 26(2): 327-+, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228823000013
31. 45381 OI-LS-323; WOS-OI-5/22/2005
Synthesis and antimycobacterial activity of ferrocenyl ethambutol analogues and ferrocenyl diamines
Razafimahefa, D, Ralambomanana, DA, Hammouche, L, Pelinski, L, Lauvagie, S, Bebear, C, Brocard, J, and Maugein, J
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2005. 15(9): 2301-2303, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228888200021
32. 45382 OI-LS-323; WOS-OI-5/22/2005
Antisense oligonucleotides inhibiting ribosomal functions in mycobacteria
Demchenko, YN, Zenkova, MA, and Vlassov, VV
BIOLOGY BULLETIN 2005. 32(2): 101-107, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228796700001
33. 45383 OI-LS-323; SCIFINDER-OI-5/24/2005
Triple Antiviral Therapy with Amantadine for IFN-Ribavirin Nonresponders with Recurrent Posttransplantation Hepatitis C
Bizollon, Thierry, Adham, Mustapha, Pradat, Pierre, Chevallier, Michelle, Ducerf, Christian, Baulieux, Jacques, Zoulim, Fabian, and Trepo, Christian
Transplantation 2005. 79(3): 325-329
34. 45384 OI-LS-323; WOS-OI-5/30/2005
A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor
Rickman, L, Scott, C, Hunt, DM, Hutchinson, T, Menendez, MC, Whalan, R, Hinds, J, Colston, MJ, Green, J, and Buxton, RS
MOLECULAR MICROBIOLOGY 2005. 56(5): 1274-1286, 13
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228975300014
35. 45385 OI-LS-323; WOS-OI-5/30/2005
Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region
Wilson, JA and Richardson, CD
JOURNAL OF VIROLOGY 2005. 79(11): 7050-7058, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229085400049
36. 45386 OI-LS-323; WOS-OI-5/30/2005
Identification of an SH3-binding motif in a new class of methionine aminopeptidases from Mycobacterium tuberculosis suggests a mode of interaction with the ribosome
Addlagatta, A, Quillin, ML, Omotoso, O, Liu, JO, and Matthews, BW
BIOCHEMISTRY 2005. 44(19): 7166-7174, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000229057600008
37. 45387 OI-LS-323; WOS-OI-5/30/2005
Inhibitory effect of aureobasidin A on Toxoplasma gondii
Sonda, S, Sala, G, Ghidoni, R, Hemphill, A, and Pieters, J
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2005. 49(5): 1794-1801, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228982600019
38. 45388 OI-LS-323; WOS-OI-5/30/2005
Inhibitory effect of 2 '-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells
Tomassini, JE, Getty, K, Stahlhut, MW, Shim, S, Bhat, B, Eldrup, AB, Prakash, TP, Carroll, SS, Flores, O, MacCoss, M, McMasters, DR, Migliaccio, G, and Olsen, DB
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2005. 49(5): 2050-2058, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228982600052
39. 45389 OI-LS-323; WOS-OI-5/30/2005
HCV anti-viral agents
Griffith, RC, Lou, L, Roberts, CD, and Schmitz, U
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39 2004. 39: 223-237, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228477500018